As an extension of his extensive experience in numerous areas of clinical research and experience with the regulatory environment, Frank can be a valuable member of any scientific advisory board, mock FDA advisory committee meeting rehearsal, or research review board.   He serves that role with PCORI and the California Institute of Regenerative Medicine on a routine basis and on safety advisory boards for several other clients.   This background allows him to review documentation for scientific accuracy and clarity and provide advice on how research proposals might be viewed by other regulatory and other scientific advisory boards.